Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Abbott Laboratories buy Raymond James

Start price
€100.30
03.01.24 / 50%
Target price
€113.61
03.01.25
Performance (%)
-0.21%
Price
€99.07
13:03
Summary
This prediction is currently active. Since the start of the prediction for Abbott Laboratories the price has only changed by -0.21%. Dividends of €1.02 are taken into consideration when calculating the performance. This prediction currently runs until 03.01.25. The prediction end date can be changed by Raymond_James at any time. Raymond_James has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Abbott Laboratories -2.090% -2.090%
iShares Core DAX® -0.922% -1.078%
iShares Nasdaq 100 0.371% -0.556%
iShares Nikkei 225® 2.224% -2.825%
iShares S&P 500 -0.026% -0.788%

Comments by Raymond_James for this prediction

In the thread Discuss Abbott Laboratories
Prediction Buy
Perf. (%) -0.21%
Target price 113.609
Change
Ends at 03.01.25

Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at Raymond James from $110.00 to $124.00. They now have an "outperform" rating on the stock.
Ratings data for ABT provided by MarketBeat

Stopped prediction by Raymond_James for Abbott Laboratories

buy
Abbott Laboratories

Start price
Target price
Perf. (%)
€102.62
25.01.24
€116.71
25.01.25
-2.96%
13:03

buy
Abbott Laboratories

Start price
Target price
Perf. (%)
€88.90
19.10.23
€104.02
19.10.24
12.58%
13:03